As anatomic pathology laboratories face declining reimbursements and other challenges to their bottom lines, one possible solution could involve collaboration with biopharmaceutical companies. But what exactly are drug companies looking for, and how can labs forge those relationships? Three biopharma executives addressed these questions during a session at the 2025 Executive War College. “The needs […]
Pathology Lab Opportunities for Biopharma Collaboration
Once pathology groups identify biopharma needs, they can then begin to serve as problem solvers
- By Stephen Beale
- > From the Volume XXXIII, No. 4 - March 23, 2026 Issue
- Tags: Agilent, Anatomic pathology, AstraZeneca, BioNTech, Biopharma, Companion diagnostics, Eli Lilly, executive war college, FDA regulation, Flatiron Health, Friends of Cancer Research, Jay White PhD, Jennifer Quigley, lab intelligence, laboratory-developed test, leakage points, Lilly Oncology, LinkedIn, Mayo Clinic Laboratories, medical science liaison, Molecularly Informed Lung Cancer Treatment in a Community Cancer Network, MSL, MYLUNG consortium, Omar Perez MD, Personalized Medicine Coalition, PharmD, precision health, Precision Medicine Coalition, Roche, Thermo Fisher, William Morice MD PhD
